comparemela.com

Latest Breaking News On - Theseus pharmaceuticals price performance - Page 1 : comparemela.com

Foresite Capital Management V LLC Has $11.05 Million Position in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX)

Foresite Capital Management V LLC Has $11.05 Million Position in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Quarter-for-theseus-pharmaceuticals
Nasdaq
Theseus-pharmaceuticals-price-performance
Tower-research-capital
Theseus-pharmaceuticals-inc
Foresite-capital-management
Securities-exchange-commission
Forefront-analytics
Theseus-pharmaceuticals-profile

Denali Advisors LLC Increases Position in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX)

Denali Advisors LLC boosted its stake in shares of Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Free Report) by 675.2% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 127,900 shares of the company’s stock after purchasing an additional 111,400 shares during the period. Denali Advisors LLC owned approximately 0.29% […]

United-states
American
Quarter-for-theseus-pharmaceuticals
Theseus-pharmaceuticals-profile
American-international-group-inc
News-ratings-for-theseus-pharmaceuticals-daily
Theseus-pharmaceuticals
Tower-research-capital
Nasdaq
Wells-fargo-company
Denali-advisors

Theseus Pharmaceuticals (NASDAQ:THRX) Trading Down 0.4%

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Get Free Report)’s share price traded down 0.4% during trading on Tuesday . The stock traded as low as $2.27 and last traded at $2.30. 105,762 shares changed hands during trading, a decline of 68% from the average session volume of 335,687 shares. The stock had previously closed at $2.31. […]

Stifel-nicolaus
Theseus-pharmaceuticals-price-performance
Institutional-investors-weigh-in-on-theseus-pharmaceuticals
Cantor-fitzgerald
Denali-advisors
Nasdaq
News-ratings-for-theseus-pharmaceuticals-daily
Theseus-pharmaceuticals-inc
Needham-company
Affinity-asset-advisors
Jump-financial
Fairmount-funds-management

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Expected to Post Q1 2024 Earnings of ($0.33) Per Share

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Expected to Post Q1 2024 Earnings of ($0.33) Per Share
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Carll-gordon
Stifel-nicolaus
Barclays-plc
Theseus-pharmaceuticals
Securities-exchange-commission
Theseus-pharmaceuticals-company-profile
Theseus-pharmaceuticals-price-performance
Nasdaq
American-international-group-inc
News-ratings-for-theseus-pharmaceuticals-daily

Insider Buying: Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Director Buys 479,932 Shares of Stock

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Get Free Report) Director Carl L. Gordon bought 479,932 shares of the company’s stock in a transaction on Monday, July 17th. The shares were bought at an average price of $3.05 per share, for a total transaction of $1,463,792.60. Following the completion of the acquisition, the director now directly owns […]

United-states
American
Stifel-nicolaus
Carll-gordon
Cantor-fitzgerald
Needham-company
Barclays-plc
Theseus-pharmaceuticals
News-ratings-for-theseus-pharmaceuticals-daily
Theseus-pharmaceuticals-inc
Hedge-funds-weigh-in-on-theseus-pharmaceuticals
Theseus-pharmaceuticals-price-performance

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.